In recent years, more patients with multiple tumors have been identified, a result of more sensitive imaging techniques that can reveal tiny, once-hidden cancers.
A recent study found the drug combination lenalidomide + rituximab is a durable, effective and safe alternative to the standard regimen combining rituximab and chemotherapy.